Iovance Biotherapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Iovance Biotherapeutics Inc
CIK #0001425205
EDGAR Form CIK 2011 - 2025
10-K [0001425205]
10-Q [0001425205]
3 [0001425205]
4 [0001425205]
5 [0001425205]
8-K [0001425205]
D [0001425205]
SC 13D [0001425205]
SC 13G [0001425205]
Form 13D/13G Filer Form 13D/13G Subject Filed
Perceptive Advisors LLC Iovance Biotherapeutics Inc [2024-03-01]
Point72 Asset Management LP Iovance Biotherapeutics Inc [2023-02-17]
BlackRock Inc Iovance Biotherapeutics Inc [2023-02-03]
State Street Corp Iovance Biotherapeutics Inc [2023-02-02]
MHR Fund Management LLC Iovance Biotherapeutics Inc [2022-12-30]
Wellington Management Group LLP Iovance Biotherapeutics Inc [2022-02-04]
ARK Investment Management LLC Iovance Biotherapeutics Inc [2021-01-11]
Price T Rowe Associates Inc /MD/ Iovance Biotherapeutics Inc [2020-02-14]
Vanguard Group Inc Iovance Biotherapeutics Inc [2020-02-11]
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2019-02-14]
Perceptive Advisors LLC Iovance Biotherapeutics Inc [2019-02-14]
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2018-02-14]
Broadfin Capital LLC Iovance Biotherapeutics Inc [2018-02-13]
BlackRock Inc Iovance Biotherapeutics Inc [2018-01-25]
Acuta Capital Partners LLC Lion Biotechnologies Inc [2017-02-13]
OrbiMed Advisors LLC Lion Biotechnologies Inc [2017-02-13]
Franklin Resources Inc Lion Biotechnologies Inc [2017-02-07]
Quogue Capital LLC Lion Biotechnologies Inc [2016-06-13]
RS Investment Management Co LLC Lion Biotechnologies Inc [2016-02-12]
venBio Select Advisor LLC Lion Biotechnologies Inc [2016-02-12]
Broadfin Capital LLC Lion Biotechnologies Inc [2016-02-11]
BlackRock Inc Lion Biotechnologies Inc [2016-01-28]
Perceptive Advisors LLC Lion Biotechnologies Inc [2015-02-17]
FMR LLC Lion Biotechnologies Inc [2014-07-10]
Alpha Capital Anstalt Lion Biotechnologies Inc [2014-01-02]
Ayer Capital Management LP Genesis Biopharma Inc [2013-06-03]
[2013-01-09]
Form 3/4/5 Subject 2011 - 2025
Iovance Biotherapeutics Inc
Roche Corleen M.
Rosinack Matthew W.
Weiser Michael
Dukes Iain D.
Yarno Wendy L
Countouriotis Athena
Maynard Ryan D
Kirby Daniel Gordon
Bellemin Jean-Marc
View All
Terms | Privacy | Guide
tony@aum13f.com